JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB26483

Anti-Cdc20 抗体

Anti-Cdc20 antibody

5

(1 Review)

|

(21 Publications)

Rabbit Polyclonal CDC20 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 21 publications.

別名を表示する

Cell division cycle protein 20 homolog, p55CDC, CDC20

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-Cdc20 antibody (AB26483)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Cdc20 antibody (AB26483)

ab26483 staining Cdc20 in HeLa cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab26483 at 1µg/ml and ab6046, Rabbit polyclonal to beta Tubulin - Loading Control. Cells were then incubated with ab150117, Goat polyclonal Secondary Antibody to Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution (shown in green) and ab150080, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 594) at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue). Also suitable in cells fixed with 4% paraformaldehyde (10 min).Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Western blot - Anti-Cdc20 antibody (AB26483)
  • WB

Project

Western blot - Anti-Cdc20 antibody (AB26483)

ab26483 consistently detects a band at 55-60 kDa but we also see bands of ~35 and 70 kDa that appear with varying intensity in some of our extracts. We cannot find an explanation for this and are unsure of the nature of these crossreacting bands.

All lanes:

Western blot - Anti-Cdc20 antibody (ab26483) at 1 µg/mL

Lane 1:

Raji (Human Burkitt's lymphoma cell line) Whole Cell Lysate (ab7908) at 20 µg

Lane 2:

Western blot - THP-1 whole cell lysate (<a href='/products/cell-lysates/thp-1-whole-cell-lysate-ab7913'>ab7913</a>) at 20 µg

Lane 3:

Western blot - HEK-293 whole cell lysate (<a href='/products/cell-lysates/hek-293-whole-cell-lysate-ab7902'>ab7902</a>) at 20 µg

Lane 4:

Western blot - HL-60 whole cell lysate (<a href='/products/cell-lysates/hl-60-whole-cell-lysate-ab7914'>ab7914</a>) at 20 µg

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution

Predicted band size: 55 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Chicken": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Pig": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Cdc20 also known as cell division cycle 20 is an important regulatory protein in the cell cycle. It plays an essential role in the anaphase-promoting complex/cyclosome (APC/C) a large ubiquitin ligase complex important for the progression of the cell cycle. Cdc20 is expressed in various tissues acting as a cell cycle regulator during mitosis. It has a molecular weight of approximately 55 kDa. The Cdc20 protein ensures the timely degradation of key mitotic inhibitors facilitating proper chromosome segregation and mitotic exit by tagging these inhibitors for proteasomal degradation.
Biological function summary

Cdc20 acts as an activator of the APC/C complex regulating the transition from metaphase to anaphase during cell division. This transition depends on the degradation of securin and cyclins ensuring correct chromosome separation and cell cycle progression. By forming a complex with APC/C Cdc20 functions to target proteins for destruction modulating cell division dynamically. Its activity ensures that chromosomes are correctly aligned and segregated preventing errors during cell division that may lead to genomic instability.

Pathways

Cdc20 integrates itself into the spindle assembly checkpoint (SAC) and the mitotic exit network (MEN). These pathways monitor chromosome alignment and ensure that cells do not proceed to anaphase until all chromosomes are properly attached to the spindle apparatus. SAC utilizes Cdc20 to regulate its inhibitory role until chromosome alignment is confirmed after which Cdc20 activates APC/C to drive anaphase onset. Moreover proteins such as BubR1 interact with Cdc20 within the SAC to inhibit premature activation of APC/C while conditions are not optimal.

Cdc20 has significant connections with cancer and chromosomal instability syndromes. Overexpression or malfunction of Cdc20 often links with various cancers such as colorectal cancer where it drives an uncontrolled cell division rate and contributes to tumorigenesis. Additionally the improper regulation of Cdc20 can impact proteins like Mad2 disrupting the spindle checkpoint and leading to aneuploidy. This disruption often ties to chromosomal instability observed in cancerous cells highlighting its role as a potential target for therapeutic intervention.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Substrate-specific adapter of the anaphase promoting complex/cyclosome (APC/C) complex that confers substrate specificity by binding to substrates and targeting them to the APC/C complex for ubiquitination and degradation (PubMed : 9734353, PubMed : 27030811, PubMed : 29343641). Recognizes and binds the destruction box (D box) on protein substrates (PubMed : 29343641). Involved in the metaphase/anaphase transition of cell cycle (PubMed : 32666501). Is regulated by MAD2L1 : in metaphase the MAD2L1-CDC20-APC/C ternary complex is inactive and in anaphase the CDC20-APC/C binary complex is active in degrading substrates (PubMed : 9811605, PubMed : 9637688). The CDC20-APC/C complex positively regulates the formation of synaptic vesicle clustering at active zone to the presynaptic membrane in postmitotic neurons (By similarity). CDC20-APC/C-induced degradation of NEUROD2 induces presynaptic differentiation (By similarity). The CDC20-APC/C complex promotes proper dilation formation and radial migration by degrading CCDC41 (By similarity).
See full target information Cell division cycle protein 20 homolog

文献 (21)

Recent publications for all applications. Explore the full list and refine your search

Journal of molecular histology 56:144 PubMed40285932

2025

Identification of the oncogenic role of centromere protein M in non-small cell lung cancer via CDC20/MYBL2/Wnt signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Wu,Jun Li,Haoyu Wang,Xu Chang,Qinglong Kong

EMBO reports 26:1036-1061 PubMed39838194

2025

High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Siqi Zheng,Linoy Raz,Lin Zhou,Yael Cohen-Sharir,Ruifang Tian,Marica Rosaria Ippolito,Sara Gianotti,Ron Saad,Rene Wardenaar,Mathilde Broekhuis,Maria Suarez Peredo Rodriguez,Soraya Wobben,Anouk van den Brink,Petra Bakker,Stefano Santaguida,Floris Foijer,Uri Ben-David

Nature 617:154-161 PubMed37100900

2023

Alternative CDC20 translational isoforms tune mitotic arrest duration.

Applications

Unspecified application

Species

Unspecified reactive species

Mary-Jane Tsang,Iain M Cheeseman

Nature aging 3:185-201 PubMed37118121

2023

Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.

Applications

Unspecified application

Species

Unspecified reactive species

Na Zhang,Qianying Hu,Tingting Sui,Lu Fu,Xinglin Zhang,Yu Wang,Xiaojuan Zhu,Baiqu Huang,Jun Lu,Zhanjun Li,Yu Zhang

OncoTargets and therapy 13:10475-10487 PubMed33116627

2020

MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chengtao Sun,Mengzhen Li,Yanfen Feng,Feifei Sun,Li Zhang,Yanjie Xu,Suying Lu,Jia Zhu,Junting Huang,Juan Wang,Yang Hu,Yizhuo Zhang

Cancers 12: PubMed32854244

2020

Kv10.1 Regulates Microtubule Dynamics during Mitosis.

Applications

Unspecified application

Species

Unspecified reactive species

Naira Movsisyan,Luis A Pardo

BMC cancer 20:552 PubMed32539694

2020

Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer L S Willoughby,Kelly George,Mark P Roberto,Hang Gyeong Chin,Patrick Stoiber,Hyunjin Shin,Chandra Sekhar Pedamallu,Scott E Schaus,Kevin Fitzgerald,Jagesh Shah,Ulla Hansen

Scientific reports 9:9924 PubMed31289358

2019

Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao Huo,Hengzi Sun,Dongyan Cao,Jiaxin Yang,Peng Peng,Mei Yu,Keng Shen

Cell division 14:5 PubMed31249607

2019

M2I-1 disrupts the in vivo interaction between CDC20 and MAD2 and increases the sensitivities of cancer cell lines to anti-mitotic drugs via MCL-1s.

Applications

Unspecified application

Species

Unspecified reactive species

Jianquan Li,Nanmao Dang,Nuria Martinez-Lopez,Paul A Jowsey,Dong Huang,Robert N Lightowlers,Fei Gao,Jun-Yong Huang

Scientific reports 7:41072 PubMed28112196

2017

The kinetochore-dependent and -independent formation of the CDC20-MAD2 complex and its functions in HeLa cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jianquan Li,Nanmao Dang,Daniel James Wood,Jun-Yong Huang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com